• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

Article

In this segment, Dr. Susan Urba, University of Michigan, Comprehensive Cancer Center, talks about treatment guidelines and decisions relevant to chemotherapy-induced nausea and vomiting (CINV) in a managed care setting.

In addition, Dr. Urba warns of the consequences associated with the treatment of CINV when cost concerns impact best practices. Often, these consequences can include increased costs from uncontrolled symptoms and potential hospital admission due to dehydration.

Related Videos
Dr Arielle Kauvar
Kavita Nair, PhD, FAAN, professor of neurology and clinical pharmacy, University of Colorado Anschutz
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Andrew Wolf, MD, assistant professor of neurology, University of Colorado Anschutz
 Rakendu Rajendran, MBBS, Virtua Health
Dr Arielle Kauvar
Patrick Sullivan, DVM, PhD
Dr Brian Koffman
Dr Brian Mulherin
Tara Carlisle, MD, PhD, assistant professor at the University of Colorado Anschutz Medical Campus
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.